Several studies have been reported for the human isotype Sirt2 in the modulation of cancer pathogenesis, inflammation, metabolic diseases, and neurodegeneration, projected the regulation of Sirt2 activity as a promising approach for pharmaceutical intrusions66. The gene discussed is SIRT2; the disease is Other metabolic disease.